These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 17295913)

  • 1. Functional analysis of splicing mutations in exon 7 of NF1 gene.
    Bottillo I; De Luca A; Schirinzi A; Guida V; Torrente I; Calvieri S; Gervasini C; Larizza L; Pizzuti A; Dallapiccola B
    BMC Med Genet; 2007 Feb; 8():4. PubMed ID: 17295913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disruption of exonic splicing enhancer elements is the principal cause of exon skipping associated with seven nonsense or missense alleles of NF1.
    Zatkova A; Messiaen L; Vandenbroucke I; Wieser R; Fonatsch C; Krainer AR; Wimmer K
    Hum Mutat; 2004 Dec; 24(6):491-501. PubMed ID: 15523642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extensive in silico analysis of NF1 splicing defects uncovers determinants for splicing outcome upon 5' splice-site disruption.
    Wimmer K; Roca X; Beiglböck H; Callens T; Etzler J; Rao AR; Krainer AR; Fonatsch C; Messiaen L
    Hum Mutat; 2007 Jun; 28(6):599-612. PubMed ID: 17311297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of NF1 allele containing two nonsense mutations in exon 37 that segregates with neurofibromatosis type 1.
    Hernández-Imaz E; Campos B; Rodríguez-Álvarez FJ; Abad O; Melean G; Gardenyes J; Martín Y; Hernández-Chico C
    Clin Genet; 2013 May; 83(5):462-6. PubMed ID: 22925204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Three different premature stop codons lead to skipping of exon 7 in neurofibromatosis type I patients.
    Wimmer K; Eckart M; Stadler PF; Rehder H; Fonatsch C
    Hum Mutat; 2000 Jul; 16(1):90-1. PubMed ID: 10874316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exhaustive mutation analysis of the NF1 gene allows identification of 95% of mutations and reveals a high frequency of unusual splicing defects.
    Messiaen LM; Callens T; Mortier G; Beysen D; Vandenbroucke I; Van Roy N; Speleman F; Paepe AD
    Hum Mutat; 2000; 15(6):541-55. PubMed ID: 10862084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel mutation in the neurofibromatosis type 1 (NF1) gene promotes skipping of two exons by preventing exon definition.
    Fang LJ; Simard MJ; Vidaud D; Assouline B; Lemieux B; Vidaud M; Chabot B; Thirion JP
    J Mol Biol; 2001 Apr; 307(5):1261-70. PubMed ID: 11292340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antisense therapeutics for neurofibromatosis type 1 caused by deep intronic mutations.
    Pros E; Fernández-Rodríguez J; Canet B; Benito L; Sánchez A; Benavides A; Ramos FJ; López-Ariztegui MA; Capellá G; Blanco I; Serra E; Lázaro C
    Hum Mutat; 2009 Mar; 30(3):454-62. PubMed ID: 19241459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NF1 gene mutations in Japanese with neurofibromatosis 1 (NF1).
    Hatta N; Horiuchi T; Watanabe I; Kobayashi Y; Shirakata Y; Ohtsuka H; Minami T; Ueda K; Kokoroishi T; Fujita S
    Biochem Biophys Res Commun; 1995 Jul; 212(2):697-704. PubMed ID: 7542886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular analysis of neurofibromatosis type 1 mutations.
    Weiming X; Yu Q; Lizhi L; Ponder M; Wallace M; Gangfeng X; Ponder B
    Hum Mutat; 1992; 1(6):474-7. PubMed ID: 1301957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Three novel mutations of the NF1 gene detected by temperature gradient gel electrophoresis of exons 5 and 8.
    Horn D; Robinson PN; Böddrich A; Buske A; Tinschert S; Nürnberg P
    Electrophoresis; 1996 Oct; 17(10):1559-63. PubMed ID: 8957181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional splicing assay shows a pathogenic intronic mutation in neurofibromatosis type 1 (NF1) due to intronic sequence exonization.
    Raponi M; Upadhyaya M; Baralle D
    Hum Mutat; 2006 Mar; 27(3):294-5. PubMed ID: 16470740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NF1 mutation rather than individual genetic variability is the main determinant of the NF1-transcriptional profile of mutations affecting splicing.
    Pros E; Larriba S; López E; Ravella A; Gili ML; Kruyer H; Valls J; Serra E; Lázaro C
    Hum Mutat; 2006 Nov; 27(11):1104-14. PubMed ID: 16937374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RT-PCR splicing analysis of the NF1 open reading frame.
    Thomson SA; Wallace MR
    Hum Genet; 2002 May; 110(5):495-502. PubMed ID: 12073021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The BRCA1 c.5434C->G (p.Pro1812Ala) variant induces a deleterious exon 23 skipping by affecting exonic splicing regulatory elements.
    Gaildrat P; Krieger S; Théry JC; Killian A; Rousselin A; Berthet P; Frébourg T; Hardouin A; Martins A; Tosi M
    J Med Genet; 2010 Jun; 47(6):398-403. PubMed ID: 20522429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aberrant splicing in several human tumors in the tumor suppressor genes neurofibromatosis type 1, neurofibromatosis type 2, and tuberous sclerosis 2.
    Kaufmann D; Leistner W; Kruse P; Kenner O; Hoffmeyer S; Hein C; Vogel W; Messiaen L; Bartelt B
    Cancer Res; 2002 Mar; 62(5):1503-9. PubMed ID: 11888927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A de novo Alu insertion results in neurofibromatosis type 1.
    Wallace MR; Andersen LB; Saulino AM; Gregory PE; Glover TW; Collins FS
    Nature; 1991 Oct; 353(6347):864-6. PubMed ID: 1719426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exon inclusion is dependent on predictable exonic splicing enhancers.
    Zhang XH; Kangsamaksin T; Chao MS; Banerjee JK; Chasin LA
    Mol Cell Biol; 2005 Aug; 25(16):7323-32. PubMed ID: 16055740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening BRCA1 and BRCA2 unclassified variants for splicing mutations using reverse transcription PCR on patient RNA and an ex vivo assay based on a splicing reporter minigene.
    Bonnet C; Krieger S; Vezain M; Rousselin A; Tournier I; Martins A; Berthet P; Chevrier A; Dugast C; Layet V; Rossi A; Lidereau R; Frébourg T; Hardouin A; Tosi M
    J Med Genet; 2008 Jul; 45(7):438-46. PubMed ID: 18424508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of six mutations in exon 37 of neurofibromatosis type 1 gene.
    Upadhyaya M; Osborn M; Maynard J; Harper P
    Am J Med Genet; 1996 Jul; 67(4):421-3. PubMed ID: 8837715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.